Holen Sie sich die Stockscreener-App
68.90
1.67%
1.13
Handel nachbörslich:
68.90
Ptc Therapeutics Inc Aktie (PTCT) Neueste Nachrichten
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) EVP Sells 829 Shares of Stock - MarketBeat
Golden Lee, PTC Therapeutics EVP, sells $56k in shares By Investing.com - Investing.com India
PTC Therapeutics (PTCT) CMO executes 829-share tax sell-to-cover - Stock Titan
PTCT (NASDAQ: PTCT) Form 144: Insider proposes sale of 2,265 shares - Stock Titan
PTC Therapeutics, Inc. (PTCT) stock price, news, quote and history - Yahoo Finance UK
How The PTC Therapeutics (PTCT) Story Is Shifting With Sephience And DMD Uncertainty - Yahoo Finance
How Investors Are Reacting To PTC Therapeutics (PTCT) Adding Veteran Dealmaker Jessica Chutter To Its Board - Sahm
Almstead, PTC Therapeutics officer, sells $3.59 million in shares By Investing.com - Investing.com Canada
PTC Therapeutics (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 52,003 Shares - MarketBeat
PTC Therapeutics (PTCT) officer sells 52,003 shares under 10b5-1 plan - Stock Titan
PTCT (NASDAQ: PTCT) lists 829 vested shares for resale; insider sales detailed - Stock Titan
PTC Therapeutics, Inc. (PTCT) Stock forecasts - uk.finance.yahoo.com
Form 144 | PTC Therapeutics(PTCT.US) Officer Proposes to Sell 3.59 Million in Common Stocks - Moomoo
Insiders sell shares at PTCT (NASDAQ: PTCT) under Rule 144, multiple trades - Stock Titan
(PTCT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Jefferies Downgrades PTC Therapeutics (PTCT) to 'Hold' with Pric - GuruFocus
PTC Therapeutics Inc (PTCT) Stock Price Quote Today & Current Price Chart - Capital.com
PTC Therapeutics, Inc. (PTCT) Latest Stock News & Headlines - Yahoo Finance
PTC Therapeutics (NASDAQ:PTCT) Earns "Hold" Rating from Jefferies Financial Group - MarketBeat
Jefferies Initiates PTC Therapeutics(PTCT.US) With Hold Rating, Announces Target Price $76 - Moomoo
PTC Therapeutics, Inc. $PTCT Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Jefferies downgrades PTC Therapeutics (PTCT) - MSN
Is It Time To Reassess PTC Therapeutics (PTCT) After Mixed Multi Year Share Performance? - Sahm
PTC Therapeutics Inc (PTCT) Stock Price, Trades & News - GuruFocus
Vanguard disaggregates holdings; reports 0 PTC Therapeutics shares (PTCT) - Stock Titan
PTC Therapeutics (PTCT) director receives new stock and option awards - Stock Titan
New PTC Therapeutics (PTCT) director Jessica Chutter files initial Form 3 - Stock Titan
PTC Therapeutics (NASDAQ:PTCT) Rating Updates Drive Nasdaq Futures Focus - Kalkine Media
PTC Therapeutics (NASDAQ:PTCT) Upgraded at Truist Financial - MarketBeat
A Look At PTC Therapeutics (PTCT) Valuation As Shares Reflect Mixed Recent Returns - Sahm
PTC Therapeutics adds Jessica Chutter to board of directors By Investing.com - Investing.com India
PTCT SEC FilingsPtc Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
PTC Therapeutics Adds Veteran Banker to Board - TipRanks
PTC Therapeutics Appoints Jessica Chutter To Board - citybiz
Ptc Therapeutics appoints biotech banking pioneer Jessica Chutter to board of directors - marketscreener.com
Ptc Therapeutics, Inc. Appoints Jessica Chutter to Board of Directors, Effective from March 24, 2026 - MarketScreener
PTC Therapeutics appoints Jessica Chutter to its board - TradingView
Biotech banker Jessica Chutter joins PTC Therapeutics (NASDAQ: PTCT) board - Stock Titan
PTC Therapeutics adds Jessica Chutter to board of directors - Investing.com
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors - Yahoo Finance
SG Americas Securities LLC Has $67.94 Million Stock Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Gains Attention After Rating Updates - Kalkine Media
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
JPMorgan Chase & Co. Trims Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz - The National Law Review
Assessing PTC Therapeutics (PTCT) Valuation As Rare Disease Growth And Sephience Execution Shape Expectations - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating PTC Therapeut - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
PTC Therapeutics or Eli Lilly: Which Stock Has More Upside? - Trefis
Between PTC Therapeutics and Eli Lilly, Which Stock Looks Set to Break Out? - Trefis
Fundamentals Check: How sensitive is PTC Therapeutics Inc to inflationPortfolio Return Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Cinctive Capital Management LP Takes Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Boxer Capital Management LLC Invests $12.27 Million in PTC Therapeutics, Inc. $PTCT - MarketBeat
What PTC Therapeutics (PTCT)'s FDA Leadership Shift Means For Its Gene and RNA Pipeline Narrative - simplywall.st
Matthew Klein Sells 2,662 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GuruFocus
PTC Therapeutics (PTCT) CEO logs RSU vesting and automatic tax share sale - Stock Titan
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):